![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
FDA Play: Redefining Breast Cancer Detection (OTC:LLBO)
Michael Vlaicu (September 18th, 2009) Writes:
Lifeline Biotechnologies Inc.
(Public, PINK:LLBO)
With the recent gains in Hard to Treat Diseases Inc. (PINK:HTDS) and BioElectronics Corp. (OTC:BIEL), investors were left hungry for more undervalued, high potential biotech companies — Then came LifeLine Biotechnologies Inc (OTC:LLBO). As technology continues to redefine the modern era of medical advancements, certain companies will stand apart from the rest, as is the case with Lifeline Biotechnologies Inc. This company is an innovative medical technology company committed to the improvement of the quality of life through exceptional health care systems, focusing on prevention, early diagnosis, and quick recovery. Recently, the company has made headlines with their innovative Breast Cancer detection system, the First Warning System ™, a dynamic test which collects information over time with an uncanny efficacy. The next several months will prove to be critical for LifeLine Biotechnologies, as they await the FDA’s decision
...achieved technology levels, BioElectronics Corp., Blue channel, breast biopsy products, Breast Cancer, breast cancer detection products, breast cancers, cancer, cancer detection system, cancer detection;, Cancers, care physician, cent;, ceo, computer software, conventional and digital mammography systems, detection systems, Diagnostic Products, Fda, health care systems;, Investing Lessons, Jim Holmes, Lifeline Biotechnologies Inc., magnetic resonance imaging, magnetic resonance imaging products, medical technology, Michael Vlaicu;, Nevada, non-breast-specific diagnostic technologies, non-imaging, non-imaging technology, nuclear imaging products, ovarian cancer, Peaceful Trading - Vlad Moraru, pharmacogenetic and prognostic testing products, physician, Reno, stage disease, Stocks to Watch, susceptibility testing products, technology advances;, Treat Diseases Inc., treatment of breast cancer, tumor, tumors, ultrasound, ultrasound products, United States, USD, various disease, What am;
At this time, StocksHaven Investments would like to recall and look back at the last few months of equity advice in order to showcase the proven track record. The following is a list of chosen companies which have been nothing short of stellar, giving investors much needed short term and long term gains despite the ongoing hostile recessionary environment.
Hard to Treat Diseases, Inc.
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.